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is expressed in many sites, notably including secondary lymphoid organs. Peripheral inoculation routes are likely to initiate most forms of spongiform encephalopathies such as sheep scrapie, bovine spongiform encephalopathy (BSE), iatrogenic Creutzfeldt-Jakob disease (CJD) and variant CJD (vCJD). Also, intracerebral (i.c.) or peripheral administration of prions to mice induces a rise of infectivity in spleen and in other lymphoid organs long before the development of neurological symptoms and neuropathological changes. Intraperitoneal inoculation has been extensively used to study the pathogenesis of transmissible spongiform encephalopathies because it causes rapid accumulation of infectivity in secondary lymphoid organs (2) (3) (4) . The question of which compartments within lymphoreticular tissues support prion replication is of relevance to public health: contamination with vCJD prions of germinal centers in lymph nodal and tonsillar follicles, for example, might call for precautionary measures in handling and sterilization of surgical instruments.
Tumor necrosis factor (TNF) and lymphotoxin (LT) ␣ signal through TNF receptor (TNFR) 1, whereas membrane-bound LT␣͞␤ heterotrimers signal through LT␤ receptor (LT␤R) (5). TNFR1 and LT␤R signaling is necessary for development and maintenance of secondary lymphoid organs (6) (7) (8) (9) (10) . LT␤R signaling is also required for maturation and maintenance of follicular dendritic cells (FDCs), which are thought to be essential for prion replication and for accumulation of diseaseassociated PrP Sc within secondary lymphoid organs. Inhibition of the LT␤ signaling pathway with a soluble receptor, which depletes FDCs (11), abolishes prion replication in spleens and prolongs the latency of scrapie after i.p. challenge (12) . B cell-deficient MT mice (13) are resistant to prions i.p. (14) , perhaps because of impaired FDC maturation (12, 15) . In addition to FDCs, PrP C -expressing hematopoietic cells are required for efficient lymphoreticular prion propagation (16, 17) .
Here, we studied peripheral prion pathogenesis in mice lacking TNF␣, LT␣͞␤, or their receptors. We report that ablation of LT␤R signaling prevents all peripheral pathogenesis, whereas ablation of TNFR1 signaling prevents prion pathogenesis in spleen but not in lymph nodes, despite the absence of FDCs.
Materials and Methods
Inoculation of Mice. Mice were inoculated i.p. with 100 l of brain homogenate containing 3-6 log LD 50 units of the Rocky Mountain laboratory (RML) scrapie strain (passage 4.1) prepared as described (18) . Mice were monitored every second day, and scrapie was diagnosed according to standard clinical criteria. Mice were killed on the day of onset of terminal clinical signs of scrapie.
Infectivity Bioassays with tga20 Indicator Mice. Assays were done on 1% spleen or lymph node homogenates. Spleens of one individual mouse, or inguinal, mesenteric, and superficial cervical lymph nodes pooled from three animals from each experimental group, were collected. Lymph nodes from every individual mouse were pooled for the experiments with fetal liver cell (FLC)-reconstituted chimeric mice. Tissues were homogenized in PBS͞5% BSA with a microhomogenizer and passed several times through 18-gauge and 22-gauge needles. When the suspension appeared homogenous, it was spun for 5 min at 500 ϫ g. Supernatants (30 l) were inoculated i.c. into groups of four tga20 mice (19) . Indicator mice were killed after development of terminal scrapie; the relationship y ϭ 11.45 Ϫ 0.088x (y, log LD 50 ͞ml of homogenate; x, incubation time in days to terminal disease) was used to calculate infectivity titers (20) .
Western Blot Analysis. Tissue homogenates were adjusted to 5 mg͞ml (brain) or 8 mg͞ml (spleen) protein and treated with proteinase K (20 g͞ml, 30 min, 37°C). Fifty micrograms (brain) or 80 g (spleen) of total protein of each sample were electro-phoresed through an SDS͞PAGE gel (12%). Proteins were transferred to nitrocellulose by semidry blotting. Membranes were blocked with TBST͞5% nonfat milk, incubated with antibodies 6H4 (brain) or 1B3 (spleen), and developed by Tris-buffered saline ϩ Tween 20 (0.05%)͞5% nonfat milk enhanced chemiluminescence (ECL, Amersham Pharmacia) as described (12) .
Immunohistochemistry and Immunofluorescence. Ten-micrometer frozen sections of spleens or lymph nodes were immunostained with the follicular dendritic cell marker FDC-M1 (clone 4C11), CD35 (8C12, PharMingen), peanut agglutinin (PNA), or the pan-B cell marker anti-CD45RO͞B220 (RA3-6B2, PharMingen) as previously described (21) .
Two-color confocal analysis was performed with antiserum XN to PrP and ER-TR9, MOMA-1, or F4͞80 on frozen acetonefixed tissue sections. For visualization we used secondary FITCconjugated F(abЈ) 2 fragments of goat immunoglobulins against rat (BioSource, Camarillo, CA) and ALEXA 546-conjugated goat anti-rabbit Ig (Molecular Probes, Leiden, The Netherlands). For controls, preimmune sera were used, or, if this option was unavailable, primary antibodies were omitted. cells) were injected into tail veins of recipients that had been lethally irradiated (1100 rad) 24 h earlier. Six to seven weeks after grafting, successful reconstitution was assessed by PCR analysis of peripheral blood taken from the retroorbital plexus for the presence or absence of the Prnp or TNFR1 gene locus as described earlier (17) .
Construction of Fetal

Results
After i.c. inoculation, all treated mice developed clinical symptoms of scrapie with incubation times similar to those of control mice (Table 1) . In all genotypes, topography and intensity of spongiosis and gliosis were similar to wild-type mice (not shown), indicating that TNF͞LT signaling is irrelevant to cerebral prion pathogenesis. Upon i.p. prion challenge, wild-type mice showed an inverse logarithmic correlation between inoculum size (3-6 log LD 50 ) and incubation time (ref. 20; Table 1 ). Instead, mice defective in LT signaling proved virtually noninfectible with Յ5 log LD 50 (Table 1) . Although these mice occasionally developed clinical disease when challenged with an extremely large inoculum (6 log LD 50 ), latency was frequently longer than in wild-type mice (Table 1) mice 450 days postinfection (dpi), indicating that defects in the LT␣͞LT␤ pathway prevent establishment of subclinical disease (22) .
In contrast, TNFR1
Ϫ/Ϫ mice were almost fully susceptible to all inoculum sizes, albeit with somewhat longer incubation times than wild-type mice (Table 1) . TNF␣ Ϫ/Ϫ mice showed dosedependent susceptibility: 6͞7 mice developed scrapie upon inoculation with 6 log LD 50 , whereas 2͞7 responded to 3 log LD 50 (Table 1) . Disease latency in those TNF␣ Ϫ/Ϫ mice that developed scrapie after 3-4 log LD 50 was vastly prolonged ( 
Wild-type Wild-type
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Mice with intact secondary lymphoid organs (TNFR2 Ϫ/Ϫ and wild-type) developed scrapie upon i.p. challenge with inocula of all sizes, while all other strains were protected to varying degrees. Mean incubation time and standard errors were calculated for mice that developed scrapie. The total observation time is indicated for mice that remained disease free. ND, not determined.
tion, and prion infectivity in spleens and lymph nodes ( Fig. 1 B  and D 1C) . Mesenteric lymph nodes pooled from three LT␤ Ϫ/Ϫ mice at 35, 60, and 90 dpi were devoid of infectivity (Fig. 1D, red  crosses) . We found no infectivity in spleens and lymph nodes of RAG1 Ϫ/Ϫ (Fig. 1D) and MT (not shown) mice at 35 dpi, except for trace amounts of prions in RAG1 Ϫ/Ϫ inguinal lymph nodes (Fig. 1D) . Therefore, ablation of mature B cells, the main suppliers of LT␣ and LT␤, may result in a phenocopy of genetic inactivation of LT␤ signaling.
Unexpectedly, all examined lymph nodes (Fig. 1D , red symbols) of TNFR1 Ϫ/Ϫ and TNF␣ Ϫ/Ϫ mice had consistently high infectivity titers across the entire incubation time (35 dpi to terminal disease). Even inguinal lymph nodes, which are distant from the injection site and do not drain the peritoneum, contained infectivity titers equal to all other lymph nodes. High lymph node titers were detected in wild-type mice and even in TNFR1 Ϫ/Ϫ mice exposed to 4 log LD 50 (Fig. 1D) , suggestive of active prion replication. We conclude that TNF deficiency prevents lymphoreticular prion accumulation in spleen but not in lymph nodes. (Fig. 2) . Next, we generated fetal liver chimeric mice to determine the cellular subsets and hematopoietic and͞or stromal components involved in prion propagation in TNFR1 Ϫ/Ϫ lymph nodes ( Table  2) that efficient lymphoreticular prion propagation required PrP C expression in both stromal and hematopoietic compartments, in our hands an extremely consistent finding (16, 17) . Two-color immunofluorescence evidenced strong PrP signals in scrapie-infected TNFR1 Ϫ/Ϫ (Fig. 3A) (Fig. 3A,  arrowheads) . Indeed, PrP colocalized with the macrophage marker ER-TR9 and MOMA-1 in wild-type lymph nodes (Fig.  3A) . (Fig. 3 A and B) .
Discussion
We show here that deletion of TNFR1 or TNF␣ preserves susceptibility to peripheral prion challenge, whereas deletion of LT signaling components confers high resistance to peripheral prion infection. These differential effects on scrapie susceptibility are surprising, because all defects (except TNFR2 Ϫ/Ϫ ) abolish FDCs, which were thought to be crucial for pathogenesis. However, LT͞TNF family members play distinct roles in lymph 
Hematopoietic cells from TNFR1 Ϫ/Ϫ mice are able to confer prion replication capability to Prnp 0/0 FLCs-reconstituted TNFR1 Ϫ/Ϫ mice indicate that a stromal component plays an additional role in prion propagation. Attack rate, number of indicator mice succumbing to scrapie͞number of mice inoculated with prions.
node induction and development (23): lymphoid organ architecture, including organization of T and B cell zones, is more severely impaired in LT-than in TNF-deficient mice (ref. 23 and data not shown). Because LT and TNF signaling defects may potentially affect several immune cell lineages, we have performed additional adoptive fetal liver cell transfer studies, which complement the gene ablation experiments.
The data above imply that prion replication can take place in secondary lymphoreticular organs even in the absence of mature FDCs, and that other cells can maintain replication of prions to titers that are similar to those of wild-type mice. Moreover, prion pathogenesis in the lymphoreticular system can be topographically compartmentalized, and lymph nodes (rather than the spleen) can represent an important reservoir of prion infectivity during disease.
We then investigated the role of hematopoietic and stromal cells for peripheral prion pathogenesis in TNFR1 Ϫ/Ϫ mice by using fetal liver chimeras. We found that hematopoietic cells from TNFR1 Ϫ/Ϫ mice restored prion replication in lymph nodes but not in spleens of Prnp 0/0 mice. On the other hand, prion loads were present also in reciprocal (Prnp 0/0 3 TNFR1 Ϫ/Ϫ ) chimeras, indicating that immature, non FDC-M1-positive FDC precursors, or other stromal cells might play an additional role in prion propagation in the lymph nodes of these mice. These findings are in line with the previous results that PrP-null hosts, recolonized with PrP-expressing hematopoietic cells, accumulated prions in lymphoid organs for Ͼ200 days after inoculation (16, 17) , and reinforce once again that a hematopoietic component, in addition to a stromal one, is required for efficient prion replication in secondary lymphoid organs in this model of prion pathogenesis.
In addition, we found now that, in the absence of mature FDCs, the PrP signal colocalized with a subset of single red-pulp, metallophilic, and marginal-zone macrophages in TNFR1 Ϫ/Ϫ lymph nodes. All of the above imply that the cells involved in prion replication and PrP Sc accumulation in the lymph nodes of TNFR1 Ϫ/Ϫ and TNF␣ Ϫ/Ϫ mice are likely to be macrophages, or some subsets thereof. This hypothesis is strengthened by the fact that, even in wild-type lymph nodes, bright PrP signals outside FDC-networks colocalized with a subset of ER-TR9-and MOMA-1-positive cells (Fig. 3A) . TNF␣ signaling through TNFR1 is required for proper homing of macrophages to the splenic marginal zone, and their absence can cause strong aberrations in macrophage subsets. However, MOMA-1 ϩ and ER-TR9 ϩ macrophages were normally distributed in the subcapsular area of TNFR1 Ϫ/Ϫ and TNF␣ Ϫ/Ϫ lymph nodes (ref. 24 , and data not shown), but were strongly disturbed in mesenteric lymph nodes of LT␤ Ϫ/Ϫ mice. If the distribution of macrophages is important for peripheral prion pathogenesis, these histoarchitectural differences may account for the differences in splenic vs. lymph nodal prion load of infected TNFR1 Ϫ/Ϫ and TNF␣ Ϫ/Ϫ mice.
Primary and secondary follicles may be functionally different in spleen vs. mesenteric lymph nodes of TNFR1 Ϫ/Ϫ mice (25) . However, we did not identify morphological differences between splenic and mesenteric germinal centers, and the TNFR1 Ϫ/Ϫ line used here (26) did not show abnormal germinal center responses after infection with vesicular stomatitis virus (21) .
The unexpected finding of high prion titers in inguinal, mesenteric, and cervical lymph nodes of TNF-deficient mice, but not in mesenteric lymph nodes of LT␤-deficient mice, indicates that prion replication within secondary lymphoid organs is LT␤R dependent, yet may occur in the absence of mature FDCs and of functional germinal centers, as revealed by the lack of PNA-positive B cell clusters. Therefore, cell types other than FDCs participate in the process of prion replication͞ accumulation in lymph nodes and, probably, in spleens. Because marginal zone macrophages might entertain close contacts to immature FDCs in the marginal zone, whose presence was postulated for the TNFR1 Ϫ/Ϫ mice (24) , and also interact with marginal zone B cells, this hematopoietic cell type is certainly a candidate for supportive effects in the process of prion uptake and replication. There is a caveat to this interpretation: immunofluorescence detects prion protein rather than infectivity, and does not differentiate unequivocally between PrP C and PrP Sc . Therefore, further studies will need to focus on whether macrophage ablation, e.g., by using macrophage-specific suicide transgenes, can suppress the infectibility of TNF-deficient lymph nodes.
These findings are at striking variance with reports that LT␤ Ϫ/Ϫ mice are fully susceptible to infection with CJD prions (27) , and that TNF␣ Ϫ/Ϫ mice peripherally challenged with ME7 prions were largely protected (28) . These and other discrepancies have been attributed to the use of different prion strains in these studies. This may well be the case, but the present data indicate that resistance in each mouse strain is dose dependent and can always be overridden (Table 1) . Therefore, challenge with one single size of inoculum, as done in other studies, may yield misleading results. Invasion of lymphoid organs by prions occurs very rapidly after peripheral inoculation, and consistently high infectivity titers are detected until terminal disease. Lymphoinvasion most likely plays an important role in the pathogenesis of vCJD, because prion infectivity can be detected in tonsils of virtually every vCJD patient (29, 30) . After lymphoinvasion, neuroinvasion occurs via autonomic nerves (31) (32) (33) (34) (35) , but the nexus between germinal centers and nerves is still elusive. By virtue of their mobility, macrophages may represent a plausible candidate for transport of prion infectivity from germinal centers to sympathetic nerve terminals. How could a possible prion amplification in macrophages be reconciled with their apparent protective role, at least in the very early phase of prion pathogenesis (36) ? Maybe the action of macrophages is dose dependent: small inocula may be destroyed by phagocytosis, whereas larger inocula cannot be digested and will be transported or amplified. Alternatively, the absence of TNFR1 may interfere directly with the interaction of macrophages and prions, because ablation of TNF signaling reduces the phagocytic ability of macrophages in several infectious models (37, 38) . Be that as it may, the fact that a cell type other than mature FDCs is involved in prion replication and accumulation within secondary lymphoid organs may help developing postexposure prophylaxis strategies aimed at blocking prion neuroinvasion.
